HbA1c antibody (Chain beta, N-Term)
Quick Overview for HbA1c antibody (Chain beta, N-Term) (ABIN7855705)
Target
See all HbA1c AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- Chain beta, N-Term
-
Purpose
- Anti-h HbA1c 2403 SPTN-5
-
Specificity
- Antibody recognizes human glycated hemoglobin A1
-
Cross-Reactivity (Details)
- Does not recognize non-glycated hemoglobin A1.
-
Characteristics
- Monoclonal mouse antibody, cultured in vitro under conditions free from animal-derived components.
-
Purity
- ≥ 95 %
-
Isotype
- IgG1
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 5.0 mg/ml
-
Buffer
- 50 mM Na-citrate, pH 6.0, 0.9 % NaCI, 0.095 % NaN3 as a preservative
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Liquid, may turn slightly opaque during storage
-
Storage
- 4 °C
-
Storage Comment
- 18 months from manufacturing at 2–8 °C
-
Expiry Date
- 18 months
-
-
- HbA1c (Glycated Hemoglobin HbA1c (HbA1c))
-
Alternative Name
- Glycated Hemoglobin HbA1c
-
Background
- Glycated hemoglobin (HbA1c) is formed in a non-enzymatic process during exposure to plasma glucose. Normal levels of glucose produce a normal amount of glycated hemoglobin. As the average amount of plasma glucose increases, the fraction of glycated hemoglobin increases in a predictable way. This serves as a marker for average blood glucose levels over the previous months prior to the measurement. The 2010 American Diabetes Association Standards of Medical Care in Diabetes added the HbA1c ≥ 48 mmol/mol (≥ 6.5 %) as another criterion for the diagnosis of diabetes.
Target
-